- Home
- NUKK vs INCR Comparison
NUKK vs INCR Comparison
Compare NUKK & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUKK
- INCR
- Stock Information
- Founded
- NUKK 2013
- INCR 1994
- Country
- NUKK United States
- INCR Israel
- Employees
- NUKK N/A
- INCR N/A
- Industry
- NUKK Blank Checks
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- NUKK Finance
- INCR Health Care
- Exchange
- NUKK Nasdaq
- INCR Nasdaq
- Market Cap
- NUKK 83.3M
- INCR 76.7M
- IPO Year
- NUKK N/A
- INCR N/A
- Fundamental
- Price
- NUKK $13.89
- INCR $1.38
- Analyst Decision
- NUKK
- INCR
- Analyst Count
- NUKK 0
- INCR 0
- Target Price
- NUKK N/A
- INCR N/A
- AVG Volume (30 Days)
- NUKK 161.7K
- INCR 10.9K
- Earning Date
- NUKK 05-15-2025
- INCR 04-08-2025
- Dividend Yield
- NUKK N/A
- INCR N/A
- EPS Growth
- NUKK N/A
- INCR N/A
- EPS
- NUKK N/A
- INCR N/A
- Revenue
- NUKK $5,913,461.00
- INCR $72,420,918.00
- Revenue This Year
- NUKK N/A
- INCR N/A
- Revenue Next Year
- NUKK N/A
- INCR $39.30
- P/E Ratio
- NUKK N/A
- INCR N/A
- Revenue Growth
- NUKK N/A
- INCR N/A
- 52 Week Low
- NUKK $1.30
- INCR $1.17
- 52 Week High
- NUKK $78.32
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- NUKK 45.72
- INCR 28.88
- Support Level
- NUKK $11.08
- INCR $1.36
- Resistance Level
- NUKK $19.79
- INCR $1.49
- Average True Range (ATR)
- NUKK 2.02
- INCR 0.06
- MACD
- NUKK -0.08
- INCR -0.01
- Stochastic Oscillator
- NUKK 32.27
- INCR 4.67
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.